Epstein Secrets

l of the Ivy League except Princeton. Last year, President Obama convened the first White House task force on col

he institutions involved, which include many of the nation's elite campuses, including all of the Ivy League except Princeton. Last year, President Obama convened the first White House task force on college sexual assault, part of a growing demand for colleges to acknowledge, measure and address the

ing a ski-instructor, amateur boxer, bar-bouncer, disc jockey and school teacher. So for all of you Canadian friends of mine who use to tell me that Barrack Obama's resume was too thin for an American President, I can't imagine what you think about your new Canadian Prime Minister. Trudeau first met his wife S

approval. Regardless of the risks, many drug companies are making huge profits. Gilead, maker of Sovaldi, has profits of around 5o percent. Biogen, Amgen and other biotech firms have profits of around 30 percent. Merck and Pfizer are seeing profits of 18 percent or more. Even if profits were cut by a

of a private mail server."' Handwritten notes from then-CIA Director John Brennan — also disclosed by Ratcliffe — say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on July 26, 2016 of a proposal from one of her foreign policy advisors to vilify Donald Trump by stirring up

liffe — say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on July

y Ratcliffe — say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

of a private mail server."' Handwritten notes from then-CIA Director John Brennan - also disclosed by Ratcliffe - say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on July 26, 2016 of a proposal from one of her foreign policy advisors to vilify Donald Trump by stirring up

liffe - say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on July

by Ratcliffe - say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

liffe - say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on July

y Ratcliffe - say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on

of a private mail server"' Handwritten notes from then-CIA Director John Brennan - also disclosed by Ratcliffe - say Brennan briefed then-President Barack Obama on 'alleged approval by Hillary Clinton on July 26, 2016 of a proposal from one of her foreign policy advisors to vilify Donald Trump by stirring u

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

up balance sheets FT • EDF to exit US nuclear power over impact of shale gas FT • Law firms are biggest users of rogue private detectives FT • Obama has set a poor test for choosing a new Fed chair FT • Don't buy the hype about Barclays' capital-raising FT • The world must learn to deal with t

om Telegraph • Business demand return of powers from Brussels Telegraph • UK economy close to 'escape velocity', say top economists Telegraph • Barack Obama open to tax amnesty Telegraph • Monetarists see recovery danger from 'Summers Fed' Telegraph • They're coming to get you, Ed, and it won't be the

scape velocity', say top economists Telegraph • Barack Obama open to tax amnesty Telegraph • Monetaris

ring @ 9pmn* ""AB,ADT,AMT,CMCSA,EXC,GRMN,H,IVZ, LVL,MA reporting pre-open"" "*ALL,CBS,DOX,DWA,MAR,MCHP,MET,WFM,YELP reporting after the close"' • Amgen revs beat ests & boosts y reps view but profit fell on higher costs (trading -1.8%) • Buffalo Wild Wings Q3 eps beat (sss weakened in July) & net j

of a private mail server"' Handwritten notes from then-CIA Director John Brennan - also disclosed by Ratcliffe - say Brennan briefed then-President Barack Obama on `alleged approval by Hillary Clinton on July 26, 2016 of a proposal from one of her foreign policy advisors to vilify Donald Trump by stirring u

liffe - say Brennan briefed then-President Barack Obama on `alleged approval by Hillary Clinton on July

y Ratcliffe - say Brennan briefed then-President Barack Obama on `alleged approval by Hillary Clinton on

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

es in healthcare systems to contain healthcare costs and improve the overall quality of care and wellness. For example, on March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act, which Congress modified pursuant to the Health Care and Education Reconciliation Act

re and wellness. For example, on March 23, 2010, President Obama signed into law the Patient Protection and Afford

t and XDx, while maintaining board observer status with Labcyte. Vijay was previously on the boards of Advanced Cell Diagnostics, Ilypsa (acquired by Amgen) and Relypsa (NASDAQ: RLYP). Prior to joining Sprout, Vijay spent one year as an analyst in the healthcare venture capital group at Robertson Stephen

quently split to become 2 separate companies), Durata Therapeutics (NLV-II: IPO - July, 2012, NASDAQ: DRTX), and Ilypsa (Sprout IX, exited in sale to Amgen, 6.9x multiple). e Established Private Companies: The New Leaf Team has played the role of lead investor in a large number of private investments. T